NASDAQ · Financial Statements

ICU Medical, Inc. (ICUI) Revenue, Earnings & Financial Statements

$176.91 NASDAQ: ICUI Market Cap $4.42B

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

ICU Medical, Inc. most recently reported annual revenue of $2.2B, net profit of $1.0M. Revenue grew at an average annual rate of 11.9% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

ICU Medical, Inc.: Revenue rose from $379.0M in 2016 to $2.2B in 2025, a change of +488.4% over 9 years; net profit was positive in 7 of 10 reported years; operating margin moved from 21.9% to 4.8%, a shift of -17.1 percentage points; the most recent year shows net profit of $1.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$379.0M$1.3B$1.4B$1.3B$1.3B$1.3B$2.3B$2.3B$2.4B$2.2B
Operating Expenses$296.0M$1.3B$1.4B$1.2B$1.2B$1.2B$2.3B$2.2B$2.3B$2.1B
Operating Profit$83.0M−$15.0M$22.0M$107.0M$98.0M$123.0M−$43.0M$23.0M$43.0M$107.0M
Operating Margin21.9%-1.2%1.5%8.5%7.7%9.4%-1.9%1.0%1.8%4.8%
Other Income$2.0M$65.0M−$7.0M$7.0M−$1.0M$0−$72.0M−$101.0M−$109.0M−$104.0M
Interest$0$2.0M$1.0M$1.0M$2.0M$1.0M$71.0M$103.0M$107.0M$105.0M
Depreciation$19.0M$67.0M$75.0M$77.0M$95.0M$90.0M$235.0M$229.0M$220.0M$201.0M
Profit Before Tax$85.0M$51.0M$22.0M$115.0M$97.0M$123.0M−$114.0M−$78.0M−$66.0M$3.0M
Tax rate (%)25.9%-33.9%-28.7%11.9%10.9%16.3%35.1%62.1%-78.3%76.9%
Net Profit$63.0M$69.0M$29.0M$101.0M$87.0M$103.0M−$74.0M−$30.0M−$118.0M$1.0M
EPS$3.66$3.29$1.33$4.69$4.02$4.74−$3.11−$1.23−$4.83$0.03

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$588.0M$567.0M$596.0M$589.0M$630.0M$605.0M$549.0M$537.0M$540.0M$530.0M$552.0M$560.0M
Operating Expenses$600.0M$577.0M$589.0M$581.0M$592.0M$592.0M$538.0M$523.0M$515.0M$500.0M$513.0M$508.0M
Operating Profit−$12.0M−$11.0M$8.0M$8.0M$38.0M$13.0M$11.0M$14.0M$25.0M$31.0M$39.0M$52.0M
Operating Margin-2.1%-1.9%1.3%1.4%6.0%2.1%1.9%2.5%4.7%5.8%7.1%9.3%
Interest$27.0M$26.0M$27.0M$27.0M$26.0M$29.0M$23.0M$20.0M$25.0M$20.0M$19.0M$18.0M
Profit Before Tax−$37.0M−$37.0M−$20.0M−$18.0M$8.0M−$11.0M$37.0M−$4.0M−$18.0M−$5.0M$23.0M$36.0M
Tax rate (%)53.3%-7.3%-9.6%-84.0%390.0%-41.9%3.2%16.2%14.4%757.6%30.6%19.9%
Net Profit−$17.0M−$39.0M−$21.0M−$33.0M−$24.0M−$15.0M$35.0M−$3.0M−$16.0M$30.0M$19.0M$27.0M
EPS−$0.71−$1.63−$0.88−$1.35−$0.97−$0.63$1.43−$0.14−$0.64$1.20$0.76$1.07

Over the 10 years reported for ICU Medical, Inc., cash stood at $308.0M in the latest year, shareholders' equity was $2.0M, current assets covered current liabilities 2.36 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$705.0M$1.5B$1.6B$1.7B$1.8B$1.9B$4.5B$4.4B$4.2B$4.1B
Current Assets$569.0M$865.0M$927.0M$882.0M$914.0M$1.0B$1.2B$1.2B$1.4B$1.2B
Cash$445.0M$290.0M$345.0M$269.0M$396.0M$553.0M$209.0M$254.0M$309.0M$308.0M
Inventory$49.0M$289.0M$311.0M$338.0M$315.0M$290.0M$696.0M$709.0M$585.0M$616.0M
Receivables$59.0M$149.0M$196.0M$202.0M$128.0M$125.0M$247.0M$182.0M$203.0M$181.0M
Fixed Assets$86.0M$399.0M$433.0M$491.0M$513.0M$511.0M$714.0M$686.0M$499.0M$506.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments−$22.0M$25.0M$39.0M$24.0M$28.0M$22.0M$8.0M$4.0M$9.0M$132.0M
Other Assets$6.0M$12.0M$11.0M$31.0M$33.0M$43.0M$1.4B$1.5B$1.4B$1.5B
Total Liabilities$45.0M$299.0M$322.0M$315.0M$261.0M$265.0M$2.4B$2.3B$2.2B$1.9B
Current Liabilities$41.0M$210.0M$249.0M$248.0M$195.0M$201.0M$495.0M$482.0M$556.0M$499.0M
Borrowings$0$0$0$36.0M$53.0M$45.0M$1.7B$1.7B$1.6B$1.4B
Other Liabilities$45.0M$299.0M$322.0M$279.0M$209.0M$220.0M$691.0M$551.0M$597.0M$534.0M
Equity$2.0M$2.0M$2.0M$2.0M$2.0M$2.0M$2.0M$2.0M$2.0M$2.0M
Reserves$660.0M$1.2B$1.3B$1.4B$1.5B$1.6B$2.1B$2.1B$2.0B$2.1B

For ICU Medical, Inc., operating cash flow was positive in 9 of 10 reported years; free cash flow in the latest year was $92.0M; free cash flow was positive in 8 of 10 years; financing activities used $9.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$90.0M$154.0M$160.0M$102.0M$223.0M$268.0M−$62.0M$166.0M$204.0M$180.0M
Investing Cash Flow−$8.0M−$347.0M−$204.0M−$273.0M−$199.0M−$172.0M−$2.0B−$182.0M−$168.0M$34.0M
Financing Cash Flow$2.0M$31.0M$8.0M−$19.0M−$13.0M−$26.0M−$13.0M−$9.0M−$15.0M−$9.0M
Net Cash Flow$109.0M−$155.0M$55.0M−$76.0M$127.0M$157.0M−$344.0M$45.0M$54.0M−$1.0M
Free Cash Flow$65.0M$75.0M$59.0M−$4.0M$122.0M$186.0M−$161.0M$73.0M$125.0M$92.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA18.63
FCF Yield4.68%
Quick Ratio1.19
Interest Coverage1.81
Return 1Y29.41%
Return 3Y104.90%
Return 5Y-26.83%

ICU Medical, Inc. (ICUI) financials — frequently asked questions

What is ICU Medical, Inc.'s annual revenue?

ICU Medical, Inc. (ICUI) reported annual revenue of $2.2B in its most recent fiscal year.

What is ICU Medical, Inc.'s net profit?

ICU Medical, Inc. (ICUI) reported net profit of $1.0M in its most recent fiscal year.

What is ICUI EV/EBITDA?

ICU Medical, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 18.63.

Revenue and earnings of other Medical - Instruments & Supplies stocks

BDX revenue $19.5BMDLN stockWST revenue $3.1BSOLV revenue $8.3BBAX revenue $11.2BCOO revenue $4.1BRGEN revenue $738.0MAVTR revenue $6.6BATR revenue $3.8BBLCO revenue $5.1BAll Medical - Instruments & Supplies stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
ICUI Overview ICUI Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.